COPD

#COPD #National Institute for Health and Care Excellence (NICE) #NHS

NICE recommends mepolizumab as COPD add-on treatment 

The National Institute for Health and Care Excellence (NICE) has recommended Nucala (mepolizumab) as an add-on treatment for NHS patients with COPD.  The draft final guidance recommends mepolizumab as an add-on maintenance treatment option for adult patients with uncontrolled COPD with raised blood eosinophils, if they are having… Read More

#News #Regulatory

Lungs
#Asthma #COPD #Drug delivery #Transpire Bio

Transpire Bio & Recipharm to develop inhaled medicines 

Pharmaceutical company Transpire Bio will work alongside drug delivery provider Recipharm to develop two inhaled medicines for the treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD).   Transpire Bio announced a definitive agreement with Recipharm to develop its TRB-1 and TRB-2 inhaled medicines. These are… Read More

#News